...Frank Hensel told BioCentury the presence of deep-pocketed investors such as BIVF and Novo afforded HepaRegeniX GmbH...
...clinical development. The company could also choose to license its molecule, he said. Paul Bonanos, Associate Editor HepaRegeniX GmbH Mitogen-activated...

...and chronic liver diseases eventually cause liver failure, the only approved treatment is liver transplantation. HepaRegeniX GmbH...
...from Ascenion GmbH , the tech transfer organization for multiple German research institutes. COMPANY PROFILE HepaRegeniX GmbH...
...covering inhibitors of MKK4 for liver regeneration Companies and Institutions Mentioned Ascenion GmbH, Munich, Germany HepaRegeniX GmbH...

...Seeds and Boehringer Ingelheim Venture Fund GmbH led a €9 million series A fund for HepaRegenix GmbH...
...Co. (NYSE:LLY), Indianapolis, Ind. Galecto Biotech AB, Copenhagen, Denmark GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. HepaRegenix GmbH...